These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 23842023)
1. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023 [TBL] [Abstract][Full Text] [Related]
2. Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform. Browne SH; Behzadi Y; Littlewort G JMIR Mhealth Uhealth; 2015 Dec; 3(4):e108. PubMed ID: 26721413 [TBL] [Abstract][Full Text] [Related]
3. Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period. Profit D; Rohatagi S; Zhao C; Hatch A; Docherty JP; Peters-Strickland TS J Clin Psychiatry; 2016 Sep; 77(9):e1095-e1100. PubMed ID: 27379966 [TBL] [Abstract][Full Text] [Related]
4. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial. Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944 [TBL] [Abstract][Full Text] [Related]
5. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability. Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821 [TBL] [Abstract][Full Text] [Related]
6. Safety Evaluation in Iterative Development of Wearable Patches for Aripiprazole Tablets With Sensor: Pooled Analysis of Clinical Trials. Jan M; Coppin-Renz A; West R; Gallo CL; Cochran JM; Heumen EV; Fahmy M; Reuteman-Fowler JC JMIR Form Res; 2023 Dec; 7():e44768. PubMed ID: 38085556 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [TBL] [Abstract][Full Text] [Related]
8. Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study. Flores GP; Peace B; Carnes TC; Baumgartner SL; Buffkin DE; Euliano NR; Smith LN Innov Clin Neurosci; 2016; 13(9-10):12-19. PubMed ID: 27974996 [No Abstract] [Full Text] [Related]
9. Optimization of a Digital Medicine System in Psychiatry. Rohatagi S; Profit D; Hatch A; Zhao C; Docherty JP; Peters-Strickland TS J Clin Psychiatry; 2016 Sep; 77(9):e1101-e1107. PubMed ID: 27487251 [TBL] [Abstract][Full Text] [Related]
10. Early clinical experience with networked system for promoting patient self-management. Au-Yeung KY; Moon GD; Robertson TL; Dicarlo LA; Epstein MS; Weis SE; Reves RR; Engel G Am J Manag Care; 2011 Jul; 17(7):e277-87. PubMed ID: 21819175 [TBL] [Abstract][Full Text] [Related]
11. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder. Citrome L Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343 [TBL] [Abstract][Full Text] [Related]
12. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
13. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
14. Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis. Fowler JC; Cope N; Knights J; Phiri P; Makin A; Peters-Strickland T; Rathod S BMJ Open; 2019 Jun; 9(6):e025952. PubMed ID: 31253613 [TBL] [Abstract][Full Text] [Related]
15. Medication adherence and activity patterns underlying uncontrolled hypertension: Assessment and recommendations by practicing pharmacists using digital health care. Noble K; Brown K; Medina M; Alvarez F; Young J; Leadley S; Kim Y; DiCarlo L J Am Pharm Assoc (2003); 2016; 56(3):310-5. PubMed ID: 27053077 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [TBL] [Abstract][Full Text] [Related]
18. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445 [TBL] [Abstract][Full Text] [Related]
19. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685 [TBL] [Abstract][Full Text] [Related]
20. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP; J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]